PHI with Patau syndrome
How does this condition affect your private health insurance?
Patau Syndrome, also known as Trisomy 13, is a severe chromosomal disorder characterized by the presence of an extra copy of chromosome 13. This genetic anomaly leads to profound developmental abnormalities affecting multiple organ systems. Infants typically present with severe intellectual disability, microcephaly, cleft lip and palate, polydactyly, heart defects, kidney malformations, and brain structural abnormalities. Seizures are common. Due to the extensive and critical health issues, most affected infants do not survive beyond the first year of life, with many succumbing within days or weeks of birth. There is no cure, and treatment focuses on supportive care.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Lifelong from birth
Duration of Illness (Lifetime)
Typically very short, often weeks to months; rarely beyond one year
Cost of Treatment (Initial)
Very high (intensive neonatal care, potential surgeries for congenital defects)
Cost of Treatment (Lifetime)
Very high (ongoing supportive care, palliative care, therapies for severe disabilities if survival is extended)
Mortality Rate
Extremely high (over 90% in the first year of life, often within days or weeks)
Risk of Secondary Damages
Nearly 100% (severe developmental delays, profound intellectual disability, multiple organ system failures, feeding difficulties, respiratory issues)
Probability of Full Recovery
Virtually 0% (incompatible with normal development; no cure for the underlying genetic condition)
Underlying Disease Risk
High (complications such as respiratory infections, heart failure, feeding difficulties, and seizures are inherent to the syndrome's manifestations)